Skip to main content
Equibles

CITADEL ADVISORS LLC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 1423053 MIAMI, FL
Back to TSHA Full portfolio

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,837,773
-$8,363,929 QoQ
Shares Held
411,135
-77.8% QoQ
Ownership
0.143%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
20 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Derivatives in TSHA

reported options exposure · as of Mar 31, 2026
CallValue
$210,984
CallShares
47,200
PutValue
$216,795
PutShares
48,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names. TSHA ranks #198 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 2,182,571 $356,894,009
2 ONC
BeOne Medicines Ltd.
 1,032,298 $306,561,536
3 BMRN
Biomarin Pharmaceutical Inc
 4,512,634 $254,918,694
4 JAZZ
Jazz Pharmaceuticals plc
 1,259,444 $238,097,887
5 MDGL
Madrigal Pharmaceuticals, Inc.
 453,843 $237,573,195
6 BBIO
BridgeBio Pharma, Inc.
 3,173,940 $235,696,783
7 TERN
Terns Pharmaceuticals, Inc.
 3,218,810 $169,695,662
8 PTGX
Protagonist Therapeutics, Inc
 1,551,900 $163,570,260

All Filings in TSHA

Export CSV
48 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $216,795 48,500
2026-03-31 $1,837,773 411,135
2026-03-31 $210,984 47,200
2025-12-31 $10,201,702 1,854,855
2025-12-31 $451,000 82,000
2025-12-31 $107,800 19,600
2025-09-30 $84,039 25,700
2025-09-30 $1,201,099 367,309
2025-06-30 $1,221,973 528,993
2025-06-30 $39,270 17,000
2025-03-31 $6,533 4,700
2025-03-31 $7,645 5,500
2025-03-31 $301,089 216,611
2024-12-31 $13,494 7,800
2024-12-31 $3,114 1,800
2024-12-31 $1,289,204 745,205
2024-09-30 $20,904 10,400
2024-09-30 $26,733 13,300
2024-09-30 $5,748,543 2,859,972
2024-06-30 $104,952 46,854
2024-06-30 $43,232 19,300
2024-06-30 $35,616 15,900
2024-03-31 $23,534 8,200
2024-03-31 $187,124 65,200
2024-03-31 $564 197
2023-12-31 $4,066,673 2,297,556
2023-12-31 $2,478 1,400
2023-12-31 $51,861 29,300
2023-09-30 $103,332 32,700
2023-09-30 $93,220 29,500
2023-06-30 $991 1,500
2023-06-30 $727 1,100
2023-06-30 $7,464 11,293
2023-03-31 $1,436 1,800
2023-03-31 $9,011 11,293
2023-03-31 $957 1,200
2022-12-31 $111,418 49,300
2022-12-31 $46,782 20,700
2022-12-31 $415,186 183,711
2022-09-30 $97,618 50,580
2022-09-30 $159,032 82,400
2022-06-30 $85,560 23,000
2022-06-30 $411,397 110,591
2022-03-31 $1,361,043 208,749
2022-03-31 $108,232 16,600
2021-12-31 $423,326 36,337
2020-12-31 $948,858 35,752
2020-09-30 $5,488,761 245,034

Report a Problem

Category
Description
Email (optional, for follow-up)